Neurallys Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$1.99M
- Investors
-
5
Neurallys General Information
Description
Developer of a neurosurgical device designed to treat hydrocephalus. The company's device is an intelligent sensor communicating with a smartphone to monitor the intracranial pressure of patients suffering from hydrocephalus, enabling neurosurgeons to have an efficient follow-up of the pathology and improve the quality of care.
Contact Information
Website
www.neurallys.comCorporate Office
- 37 Rue Des Mathurins
- 75008 Paris
- France
Corporate Office
- 37 Rue Des Mathurins
- 75008 Paris
- France
Neurallys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 21-Mar-2022 | $1.99M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 12-Mar-2019 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 26-Jul-2017 | $81.5K | $81.5K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Neurallys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
Neurallys Patents
Neurallys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3105728-A1 | Cerebrospinal fluid turbidity measuring device and associated method | Inactive | 30-Dec-2019 | ||
| EP-4084688-A1 | Device for measuring the turbidity of cerebrospinal fluid and associated method | Pending | 30-Dec-2019 | ||
| US-20230041873-A1 | Device for measuring the turbidity of cerebrospinal fluid and associated method | Inactive | 30-Dec-2019 | ||
| WO-2021136919-A1 | Device for measuring the turbidity of cerebrospinal fluid and associated method | Inactive | 30-Dec-2019 | ||
| EP-3481486-A1 | Device for detecting a malfunctioning of a ventriculoperitoneal shunt for cerebrospinal fluid | Active | 07-Jul-2016 | A61M27/006 |
Neurallys Signals
Neurallys Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Doliam | Venture Capital | Minority | ||
| Erganeo | Venture Capital | Minority | ||
| Finsify Hub | VC-Backed Company | Minority | ||
| HAC Futur | Corporation | Minority | ||
| Agoranov | Accelerator/Incubator |
Neurallys FAQs
-
When was Neurallys founded?
Neurallys was founded in 2016.
-
Where is Neurallys headquartered?
Neurallys is headquartered in Paris, France.
-
What is the size of Neurallys?
Neurallys has 3 total employees.
-
What industry is Neurallys in?
Neurallys’s primary industry is Surgical Devices.
-
Is Neurallys a private or public company?
Neurallys is a Private company.
-
What is Neurallys’s current revenue?
The current revenue for Neurallys is .
-
How much funding has Neurallys raised over time?
Neurallys has raised $2.89M.
-
Who are Neurallys’s investors?
Doliam, Erganeo, Finsify Hub, HAC Futur, and Agoranov have invested in Neurallys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process